8-K//Current report
Trillium Therapeutics Inc. 8-K
Accession 0001104659-21-140044
CIK 0001616212operating
Filed
Nov 15, 7:00 PM ET
Accepted
Nov 16, 5:07 PM ET
Size
201.7 KB
Accession
0001104659-21-140044
Documents
- 8-Ktm2132874d1_8k.htmPrimary
FORM 8-K
- EX-101.SCHtril-20211115.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABtril-20211115_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREtril-20211115_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLtm2132874d1_8k_htm.xml
IDEA: XBRL DOCUMENT
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001104659-21-140044-xbrl.zip
IDEA: XBRL DOCUMENT
Issuer
Trillium Therapeutics Inc.
CIK 0001616212
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001616212
Filing Metadata
- Form type
- 8-K
- Filed
- Nov 15, 7:00 PM ET
- Accepted
- Nov 16, 5:07 PM ET
- Size
- 201.7 KB